Address: 128 Academia Road, Section 2, Nankang, Taipei 115, Taiwan ,Taiwan
Tel: (02)27822120-9
Web: http://www.sinica.edu.tw/main_e.shtml
Academia Sinica is a modern research institution with a worldwide reputation and a proud tradition. Academia Sinica is presently positioning itself to move its research activities to the international level. Aside from placing greater emphasis on opening up new areas of intellectual endeavor, Academia Sinica is also taking a leadership role in launching new initiatives in applied areas to meet a broad spectrum of social needs in Taiwan.
Aside from placing greater emphasis on opening up new areas of intellectual endeavor, Academia Sinica is also taking a leadership role in launching new initiatives in applied areas to meet a broad spectrum of social needs in Taiwan.
Dr Fu-Tong Liu, vice president of Academia Sinica, introduces the institution and its research mission of promoting basic research and enhancing translation. Dr Liu goes on to describe Academia Sinica’s…
Academia Sinica celebrated its 80th anniversary in 2008. After this milestone, how does the institute define its activities today? Academia Sinica was founded more than eighty years ago, as the…
Carol Cheng, COO of the Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA), provides insights into the recent development of the country’s innovative biopharmaceutical industry, while she also highlights TRPMA’s eye-catching initiative…
Carol Cheng, COO of the Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA), the association gathering 28 Taiwan-based, R&D-driven biopharmaceutical companies, highlights the association’s eye-catching initiative to boost international collaboration between academia…
James Chen, founder and Chairman of the board of Vetco, the first Taiwan-based veterinary company to have successfully developed an innovative veterinary oncology product, documents the main specificities of Vetco’s…
Johnsee Lee, founder, CEO, and president of Personal Genomics and its sister company Quark Biosciences, provides insights into the company’s proprietary Optoelectronic Sequencing (OES) technology, which can perform whole genome…
Ben Chien, Chairman, President and CEO, of Foresee Pharmaceuticals, one of Taiwan’s most vibrant success stories, discusses how Foresee has achieved successful phase III results for its prostate cancer treatment,…
Dr. Hui-Ting Huang, President of Taiwan Adventist Hospital, discusses the challenges of long-term care and the role preventive medicine plays within this scope, while also providing insights on running one…
Dr. Tzu-Ling (Karen) Tseng, CEO of Bio Preventive Medicine Corporation in Taiwan, discusses the innovative technology of its patented biomarkers, the success of DNlite and company’s strategy to grow through…
C.Y. Cheng, chairman and president of Formosa Laboratories, shares exciting news about the establishment of a new drug development company, Formosa Pharmaceuticals. He explains how the know-how gained from running…
With 7,000 employees in 25 locations across 12 countries in the region, PAREXEL now has more than a third of its global staff in Asia Pacific (APAC). Albert Liou, Vice…
Chih-Yi Weng, chairlady and CEO of Charsire Biotechnology, one of Taiwan’s leading biotech companies focused on the development of botanical new drugs as well as topical and personal care products,…
Peter Tsai, founder, CEO, and chairman of Orient EuroPharma (OEP), one of the leading groups of healthcare companies in Taiwan, provides insights into his strategic vision to double the group’s…
Peter Tsai, founder, CEO, and chairman of Orient EuroPharma (OEP), one of the leading groups of healthcare companies in Taiwan, provides insights into his strategic vision to double the group’s…
See our Cookie Privacy Policy Here
